Oxalomalic acid (trisodium)
Oxalomalic acid (Oxalomalate) trisodium is a aconitase and NADP-dependent isocitrate dehydrogenase inhibitor. Oxalomalic acid trisodium inhibits nitrite production and iNOS protein expression in lipopolysaccharide -activated J774 macrophages[1].
Product Specifications
CAS Number
89304-26-7
Product Name Alternative
Oxalomalate (trisodium)
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oxalomalic-acid-trisodium.html
Purity
95.0
Solubility
H2O : 1 mg/mL (ultrasonic; warming)
Smiles
O=C(C(C(C(C(O[Na])=O)O)C(O[Na])=O)=O)O[Na]
Molecular Formula
C6H3Na3O8
Molecular Weight
272.05
Precautions
H302, H315, H319, H335
References & Citations
[1]Irace C, et al. Oxalomalate affects the inducible nitric oxide synthase expression and activity. Life Sci. 2007 Mar 13;80 (14) :1282-91.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF647 conjugate, 0.1mg/mL
Fibronectin (Fn-3), CF405S conjugate, 0.1mg/mL
Fibronectin (TV-1), CF640R conjugate, 0.1mg/mL
CD7 (T-Cell Leukemia Marker) (CD7/3737), CF405S conjugate, 0.1mg/mL
CD45RA (158-4D3), CF594 conjugate, 0.1mg/mL
